|
CRLF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.96630000007347E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.222800E-04 |
| Normal-vs-Stage2 |
3.816300E-04 |
| Normal-vs-Stage3 |
1.964060E-03 |
| Normal-vs-Stage4 |
5.092200E-02 |
| Stage1-vs-Stage2 |
6.582400E-02 |
| Stage1-vs-Stage3 |
5.026200E-01 |
| Stage1-vs-Stage4 |
4.426000E-01 |
| Stage2-vs-Stage3 |
2.829000E-01 |
| Stage2-vs-Stage4 |
6.229800E-01 |
| Stage3-vs-Stage4 |
7.592000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.79340000003603E-06 |
| Normal-vs-AfricanAmerican |
1.359270E-04 |
| Normal-vs-Asian |
4.910100E-02 |
| Caucasian-vs-AfricanAmerican |
5.687600E-01 |
| Caucasian-vs-Asian |
1.863610E-01 |
| AfricanAmerican-vs-Asian |
2.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.36320000005053E-06 |
| Normal-vs-Female |
5.93019999994837E-07 |
| Male-vs-Female |
7.203900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.563300E-03 |
| Normal-vs-Extreme_Weight |
5.609800E-04 |
| Normal-vs-Obese |
2.236200E-04 |
| Normal-vs-Extreme_Obese |
2.371600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.786600E-01 |
| Normal_Weight-vs-Obese |
3.599400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.479400E-01 |
| Extreme_Weight-vs-Obese |
4.197800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.223800E-01 |
| Obese-vs-Extreme_Obese |
6.322000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.381740E-04 |
| Normal-vs-Age(41-60Yrs) |
4.64000005084841E-09 |
| Normal-vs-Age(61-80Yrs) |
1.141830E-03 |
| Normal-vs-Age(81-100Yrs) |
6.301200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.408200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.583100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.104600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.043110E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.260000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.791800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.8722999995986E-07 |
| Normal-VS-Type2 PRCC |
1.502030E-02 |
| Normal-VS-KIRP CIMP |
1.06590000004125E-06 |
| Normal-VS-Unclassified PRCC |
1.562760E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.587780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.625600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.667240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.881600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.354200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.232200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.957100E-03 |
| Normal-vs-N1 |
3.980600E-04 |
| Normal-vs-N2 |
6.678400E-01 |
| N0-vs-N1 |
2.503800E-02 |
| N0-vs-N2 |
4.271000E-01 |
| N1-vs-N2 |
1.464250E-01 |
|
|
